Since SAHs are usually left to our neurosurgeons, we are rarely confronted with this highlight of neurointensive care. Sad enough. So we will grab the current case of an iatrogenic SAH during endovascular stroke treatment (a rupture of the ICA) to illustrate management.
- A slightly pessimistic overview from the British in Pract Neurol 2009
- An American optimistic article by the tsar of neuro-ICU EFW (Semin Neurol 2010)
- Here is an article that reviews the current status of Mg2+ (unfortunately I cannot access it)
- There are numerous studies on the various Endothelin-R-antags, but they have all been negative, including CONSCIUOS-2 (cf the recent Lancet Neurol 2011)